Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company TCF GmbH
DescriptionRecombinant HIV gp120 envelope protein
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationGraft-versus-host disease (GvHD)
Indication DetailsPrevent graft-versus-host disease (GvHD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today